KATHERINE DALEY: Open Payments
NPI 1720314289 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$983 in 42 payments from 10 companies in 2025. Trend: 2023 $884 · 2024 $783 · 2025 $983
Food & beverage: $983
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 25 | $530 |
| ABBVIE INC. | 4 | $154 |
| Regeneron Healthcare Solutions, Inc. | 2 | $63 |
| GENZYME CORPORATION | 3 | $57 |
| Galderma Laboratories, L.P. | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Amgen Inc. | 1 | $27 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $18 |
| Biofrontera Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: Sotyktu, RINVOQ, DUPIXENT, NEMLUVIO, LIBTAYO, OTEZLA, JUBLIA, TALTZ.
Industry payments across NC — which companies pay providers there.
